The potential for combining radiotherapy with immunotherapy is enormous, yet experts say that radio-immunotherapy still has a long way to go before entering into routine clinical practice One of the hot topics discussed at ESTRO38, [more]
Many patients are being treated with costly new radiotherapy treatments on the basis of hype rather than evidence that they stand to benefit. For others, lack of evidence is delaying access to new treatments that [more]
The combination of immuno-oncology and radiotherapy, new technologies, new indications, the role of artificial intelligence: these are the main topics discussed at ESTRO38, the annual congress of European Society for Radiotherapy and Oncology (ESTRO) that took [more]
According to an article published in the journal Annals of Oncology, men with early stage testicular cancer (Testicular Cancer in Clinical Stage I, or TC CS I) can be treated with one course of chemotherapy [more]
The staff of a crematorium in the United States was contaminated after dealing with the dead body of one or more persons who had died right after a radiotherapy course, raising concerns about the risk [more]
Most solid tumours will prove fatal if they are not treated with surgery and/or radiotherapy and medical therapies. But evidence is building to show that treating the primary may raise the risk of metastatic spread. [more]
The perspective of undergoing radiation therapy usually scares most breast cancer patients, but according to a new study most women treated with modern breast radiation therapy describe their experience as much better than they expected. [more]
When we talk about advances in cancer care patient advocacy groups tend to focus on the development of new drugs, immunotherapy being the latest flavour. This is encouraged by the pharma industry, keen to gain [more]
Brain tumours are tough to treat for so many reasons. Progress depends almost entirely on the steadfast commitment of doctors working within international networks. Peter McIntyre talked to some of them, to hear about their [more]
Acute skin reactions associated with radiotherapy can be distressing and can lead to treatment interruption. Anticipating, assessing and managing the problem according to best evidence can make a big difference. Radiotherapy-related toxicity occurs because of [more]
Although radiotherapy is a key component of cancer treatment, provision of this modality is not immune to limits placed on health-care expenditure. Recent studies suggest European radiation oncology resources will generally be insufficient to meet [more]
Advances in imaging and molecular biology are opening up a wealth of new avenues for research and treatment in radiotherapy. But could progress be held back by a lack of public awareness of the potential [more]
Could intelligent combinations of drugs and radiation take precision radiotherapy to new levels? Marcel Verheij believes so, but may struggle to prove it without a fairer share of funding In the mid-80s, radiotherapy looked doomed. [more]